The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma
Abstract
PURPOSE: To identify prognostic factors for survival in adult patients with cerebral low-grade glioma (LGG), to derive a prognostic scoring system, and to validate results using an independent data set. PATIENTS AND METHODS: European Organization for Research and Treatment of Cancer (EORTC) trial 22844 and EORTC trial 22845 are the largest phase III trials ever carried out in adult patients with LGG. The trials were designed to investigate the dosage and timing of postoperative radiotherapy in LGG. Cox analysis was performed on 322 patients from EORTC trial 22844 (construction set), and the results were validated on 288 patients from trial 22845 (validation set). Patients with pilocytic astrocytomas were excluded from this prognostic factor analysis. RESULTS: Multivariate analysis on the construction set showed that age ≥ 40 years, astrocytoma histology subtype, largest diameter of the tumor ≥ 6 cm, tumor crossing the midline, and presence of neurologic deficit before surgery were unfavorable prognostic factors for survival. The total number of unfavorable factors present can be used to determine the prognostic score. Presence of up to two of these factors identifies the low-risk group, whereas a higher score identifies high-risk patients. The validity of the multivariate model and of the scoring system was confirmed in the validation set. CONCLUSION: In adult patients with LGG, older age, astrocytoma histology, presence of neurologic deficits before surgery, largest tumor diameter, and tumor crossing the midline were important prognostic factors for survival. These factors can be used to identify low-risk and high-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Shaw, E., Arusell, R., Scheithauer, B., O’Fallon, J., O’Neill, B., Dinapoli, R., Nelson, D., Earle, J., Jones, C., Cascino, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.126 · Cited by 730
Karim, A. B. M. F., Maat, B., Hatlevoll, R., Menten, J., Rutten, E. H. J. M., Thomas, D. G. T., Mascarenhas, F., Horiot, J. C., Parvinen, L. M., van Reijn, M., et al. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00352-5 · Cited by 694 · cited 2×
“This analysis revealed some different findings as compared with a previous prognostic factor analysis on the construction set.(3) The differences are mainly due to the exclusion in the present analysis of patients with WHO grade 1 astrocytoma subtype and to the more mature character of the construction set at the time…”
BackgroundResultSelf-citationKhanna, C., Anderson, P. M., Hasz, D. E., Katsanis, E., Neville, M., & Klausner, J. S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 561
Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres
Laws, E. R., Taylor, W. F., Clifton, M. B., & Okazaki, H. (1984) · Journal of Neurosurgery · doi:10.3171/jns.1984.61.4.0665 · Cited by 512
Karim, A. B. M. F., Afra, D., Cornu, P., Bleehan, N., Schraub, S., De Witte, O., Darcel, F., Stenning, S., Pierart, M., & Van Glabbeke, M. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02692-x · Cited by 389
Self-citationLeighton, C., Fisher, B., Bauman, G., Depiero, S., Stitt, L., MacDonald, D., & Cairncross, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1294 · Cited by 365
Radiation therapy in the management of low-grade supratentorial astrocytomas
Shaw, E. G., Daumas-Duport, C., Scheithauer, B. W., Gilbertson, D. T., O'Fallon, J. R., Earle, J. D., Laws, E. R., & Okazaki, H. (1989) · Journal of Neurosurgery · doi:10.3171/jns.1989.70.6.0853 · Cited by 326
Treatment and Survival of Low-Grade Astrocytoma in Adults--1977–1988
McCormack, B. M., Miller, D. C., Budzilovich, G. N., Voorhees, G. J., & Ransohoff, J. (1992) · Neurosurgery · doi:10.1097/00006123-199210000-00004 · Cited by 257
Suspected low‐grade glioma: Is deferring treatment safe?
Recht, L. D., Lew, R., & Smith, T. W. (1992) · Annals of Neurology · doi:10.1002/ana.410310413 · Cited by 250
Variations in the History and Survival of Patients with, Supratentorial Low-grade Astrocytomas
Piepmeier, J., Susan Christopher, R. N., Spencer, D., Byrne, T., Kim, J., Knisel, J. P., Lacy, J., Tsukerman, L., & Makuch, R. (1996) · Neurosurgery · doi:10.1097/00006123-199605000-00002 · Cited by 249
Molecular Genetic Evidence for Subtypes of Oligoastrocytomas
MAINTZ, D., FIEDLER, K., KOOPMANN, J., ROLLBROCKER, B., NECHEV, S., LENARTZ, D., STANGL, A. P., LOUIS, D. N., SCHRAMM, J., WIESTLER, O. D., et al. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00003 · Cited by 247
Lote, K., Egeland, T., Hager, B., Stenwig, B., Skullerud, K., Berg-Johnsen, J., Storm-Mathisen, I., & Hirschberg, H. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.9.3129 · Cited by 236
van Veelen, M. L. C., Avezaat, C. J. J., Kros, J. M., van Putten, W., & Vecht, C. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.5.581 · Cited by 230
Self-citationObservations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres
Piepmeier, J. M. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.67.2.0177 · Cited by 208
Low grade supratentorial astrocytomas. Management and prognostic factors
Janny, P., Cure, H., Mohr, M., Heldt, N., Kwiatkowski, F., Lemaire, J.-J., Plagne, R., & Rozan, R. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1937::aid-cncr2820730727>3.0.co;2-g · Cited by 186
Prognostic factors in well-differentiated cerebral astrocytomas in the adult
Soffietti, R., Chi??, A., Giordana, M. T., Vasario, E., & Schiffer, D. (1989) · Neurosurgery · doi:10.1097/00006123-198905000-00005 · Cited by 181
Prognostic Factors in Well-Differentiated Cerebral Astrocytomas in the Adult
Soffietti, R., Chioò, A., Giordana, M. T., Vasario, E., & Schiffer, D. (1989) · Neurosurgery · doi:10.1227/00006123-198905000-00005 · Cited by 168
Shibamoto, Y., Kitakabu, Y., Takahashi, M., Yamashita, J., Oda, Y., Kikuchi, H., & Abe, M. (1993) · Cancer · Cited by 140
Scerrati, M., Roselli, R., Iacoangeli, M., Pompucci, A., & Rossi, G. F. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.291 · Cited by 132
Nicolato, A., Gerosa, M. A., Fina, P., Iuzzolino, P., Giorgiutti, F., & Bricolo, A. P. (1995) · Surgical Neurology · doi:10.1016/0090-3019(95)00184-0 · Cited by 114
Donahue, B., Scott, C., Nelson, J. S., Rotman, M., Murray, K. J., Nelson, D. F., Banker, F. L., Earle, J. D., Fischbach, J. A., Asbell, S. O., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00126-0 · Cited by 111
Supratentorial World Health Organization Grade 2 astrocytomas and oligoastrocytomas
Kreth, F. W., Faist, M., Rössner, R., Volk, B., & Ostertag, C. B. (1997) · Cancer · Cited by 103
Oligoastrocytomas: a clinicopathological study of 52 cases
Krouwer, H. G. J., van Duinen, S. G., Kamphorst, W., et al. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005731305078 · Cited by 49
Supratentorial Low-Grade Glioma: Results and Prognostic Factors Following Postoperative Radiotherapy
Grabenbauer, G. G., Rödel, C. M., Paulus, W., et al. (2000) · Strahlentherapie und Onkologie · doi:10.1007/s000660050007 · Cited by 40
Berger (1994) · doi:10.1002/1097-0142(19940915)74:6<1784::aid-cncr2820740622>3.0.co;2-d
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas
Smith, J. S., Chang, E. F., Lamborn, K. R., Chang, S. M., Prados, M. D., Cha, S., Tihan, T., VandenBerg, S., McDermott, M. W., & Berger, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9337 · Cited by 1,283
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
van den Bent, M., Afra, D., de Witte, O., Hassel, M. B., Schraub, S., Hoang-Xuan, K., Malmström, P.-O., Collette, L., Piérart, M., Mirimanoff, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67070-5 · Cited by 1,035
Self-citation
Metadata
- Authors
- Pignatti, F., van den Bent, M., Curran, D., Debruyne, C., Sylvester, R., Therasse, P., Áfra, D., Cornu, P., Bolla, M., Vecht, C., & Karim, A. B. M. F.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-04-15
- Volume
- 20
- Issue
- 8
- Pages
- 2076-2084
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2116232743
- Cited by
- 955
- References
- 28
- FWCI
- 10.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.